Multimedia
May 20, 2021
The Effect of H.R. 3 on Drug Prices and Innovation
Christopher Holt
AAF’s Director of Health Care Policy Christopher Holt explains why Democrats’ proposed drug-pricing legislation, H.R. 3, will restrict drug availability and innovation.
Recent Posts
Appears in: